We are live on ! Find out more
LVGO

Livongo Health, Inc. Common Stock
LVGO

Delisted

LVGO was delisted on the 29th of October, 2020.

Back to rankings

0 hedge funds and large institutions have $0 invested in Livongo Health, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 388 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 391 → 0 (-391)

100% less funds holding in top 10

Funds holding in top 10: 27 → 0 (-27)

100% less capital invested

Capital invested by funds: $7B → $0 (-$7B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 388

Holders
–
Holders Change
-391
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-27
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
388
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

1
Vanguard Group
Vanguard Group
Pennsylvania
-$734M
2
BlackRock
BlackRock
New York
-$554M
3
Morgan Stanley
Morgan Stanley
New York
-$427M
4
HI
HBK Investments
Texas
-$390M
5
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
-$372M
Name Holding Trade Value Shares
Change 		Change in
Stake
IA
51
IndexIQ Advisors
New York
– -$32.2M -230,256 Closed
ACM
52
Ashford Capital Management
Delaware
– -$30.9M -220,730 Closed
WC
53
Westwind Capital
New Mexico
– -$29.6M -211,595 Closed
Citadel Advisors
54
Citadel Advisors
Florida
– -$29M -206,785 Closed
BG
55
Bellevue Group
Switzerland
– -$28.5M -203,329 Closed
Bank of New York Mellon
56
Bank of New York Mellon
New York
– -$26.8M -191,542 Closed
UBS AM
57
UBS AM
Illinois
– -$25.2M -179,647 Closed
RPAM
58
Rhenman & Partners Asset Management
Sweden
– -$23.4M -166,961 Closed
Two Sigma Advisers
59
Two Sigma Advisers
New York
– -$22.3M -159,100 Closed
Charles Schwab
60
Charles Schwab
California
– -$22.1M -157,980 Closed
Wells Fargo
61
Wells Fargo
California
– -$22M -157,426 Closed
AC
62
Athanor Capital
New York
– -$21.9M -156,730 Closed
Balyasny Asset Management
63
Balyasny Asset Management
Illinois
– -$21.8M -155,485 Closed
BHMP
64
Bardin Hill Management Partners
New York
– -$21.6M -154,400 Closed
Grantham, Mayo, Van Otterloo & Co (GMO)
65
Grantham, Mayo, Van Otterloo & Co (GMO)
Massachusetts
– -$19.8M -141,300 Closed
AllianceBernstein
66
AllianceBernstein
Tennessee
– -$19.5M -138,935 Closed
JP Morgan Chase
67
JP Morgan Chase
New York
– -$19.2M -138,785 Closed
UBS Group
68
UBS Group
Switzerland
– -$19.2M -137,338 Closed
CCM
69
Chicago Capital Management
Illinois
– -$18.8M -134,542 Closed
PCM
70
Pentwater Capital Management
Florida
– -$17.7M -126,495 Closed
CIBC Private Wealth Group
71
CIBC Private Wealth Group
Georgia
– -$17M -121,581 Closed
First Trust Advisors
72
First Trust Advisors
Illinois
– -$16.6M -118,677 Closed
California Public Employees Retirement System
73
California Public Employees Retirement System
California
– -$16.2M -115,400 Closed
Adage Capital Partners
74
Adage Capital Partners
Massachusetts
– -$15M -106,972 Closed
ACM
75
Atika Capital Management
New York
– -$14.2M -101,052 Closed
1 2
3
4 5

LVGO Hedge Fund Activity: Q4 2020 in Review

0 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Livongo Health, Inc. Common Stock (LVGO) for Q4 2020, worth a combined $0 — down 100% from $7B a quarter earlier.

Sellers outnumbered buyers: 388 funds closed out of LVGO and 0 opened new positions — a net loss of 388 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $734M sold.

  • 0 institutional investors held Livongo Health, Inc. Common Stock (LVGO) as of Q4 2020, down from 391 in Q3 2020.
  • Funds reported $0 of Livongo Health, Inc. Common Stock stock for Q4 2020, down 100% quarter-over-quarter.
  • 0 funds opened new Livongo Health, Inc. Common Stock positions in Q4 2020 and 388 closed out, a net change of -388 holders.
  • The largest Livongo Health, Inc. Common Stock seller in Q4 2020 was Vanguard Group, an estimated $734M sold.

Based on aggregated 13F filings for Q4 2020.